Vyne Therapeutics Inc (NASDAQ:VYNE)
| 0.2637 Delayed Data As of Feb 03 |  +0.0047 / +1.81%Today’s Change | 0.11 Today|||52-Week Range 0.79 | +75.80% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 43.8M | 4.0M | 10.2M | 49.5M | |
| Short Term Investment Cash | 43.5M | -39.8M | 6.2M | 39.3M | ||
| Cash & Short Term Investments | 43.8M | 30.9M | 59.5M | 136.3M | ||
| Receivables | Receivables | 0.00 | 0.00 | 786.0K | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 77.0K | 632.0K | 3.6M | 3.3M | |
| Current Assets | 43.9M | 31.5M | 63.9M | 139.5M | ||
| Total Assets | Other Assets | 0.00 | 66.0K | 0.00 | 282.0K | |
| Total Assets | 43.9M | 42.1M | 66.9M | 139.9M | ||
| Liabilities | Accounts Payable | 637.0K | 1.5M | 2.5M | 3.3M | |
| Accrued Expenses | 80.0K | 245.0K | 2.3M | 3.3M | ||
| Other Current Liabilities | 133.0K | 2.1M | 4.2M | 3.6M | ||
| Other Liabilities | 770.0K | 3.9M | 7.8M | 9.5M | ||
| Total Liabilities | Other Liabilities | 65.0K | 57.0K | 22.0K | 7.0K | |
| Total Liabilities | 835.0K | 12.5M | 14.6M | 9.6M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 59.0M | 59.0M | 109.3M | 0.00 | ||
| Common Equity | -16.0M | -29.4M | -57.0M | 130.4M | ||
| Total Shareholder Equity | 43.1M | 29.6M | 52.3M | 130.4M | ||
| Share Information | Common Shares Outstanding | 21.4M | 23.0M | 23.0M | 23.2M | |
| Addtl. Info. | No data currently available for this section. | |||||
